Please assess the completion status of the following clinical trial:

Trial Title: Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Burkitt's leukemia or Burkitt's lymphoma or primary mediastinal large B-cell lymphoma or B-precursor lymphoblastic lymphoma or large cell anaplastic lymphoma~* Age \> 15 years~* Written informed consent~Exclusion Criteria:~* Serious secondary diseases, including psychiatric conditions, under which the required therapy compliance is not to be expected~* HIV infection~* Secondary lymphoma following prior chemotherapy/radiotherapy or active second malignancy~* Known severe allergy to foreign proteins~* Pre-treatment other than 1 cycle CHOP or similar; \< 1 week of another chemotherapy.~* Pregnancy or nursing~* Participation in other studies that interfere with study therapy

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Experimental (Type: EXPERIMENTAL): This is a single arm trial with complex chemotherapy (6 cycles) stratified by age, subtype (Burkitt-leukemia vs Burkitt-lymphoma) and initial involvement

Based on this trial design, predict the completion outcome and termination type (if applicable).